Xarelto 20 MG tablet 1000S
Ended Awarded
- Contract number
- SPE2DR26FG1EN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $60,885
Award facts
- Contract value 100% obligated
- $60,885.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $60,885.15 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Xarelto 20 mg, an anticoagulant medication. Issued on November 18, 2025, with a completion deadline of November 19, 2025, this firm fixed-price contract was awarded competitively without set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger IDC vehicle with DLA Troop Support Medical (SPE2DX), a $999.9 billion indefinite delivery contract through December 2026 that authorizes the company to supply pharmaceutical products and medical supplies to support military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its comprehensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's extensive federal contract history demonstrates consistent capability in fulfilling diverse pharmaceutical supply requirements across multiple therapeutic domains for military and veteran healthcare systems, the Defense Health Agency, and the U.S. Coast Guard. This particular delivery order for Xarelto exemplifies the company's role in ensuring adequate pharmaceutical inventory within the DLA's medical supply chain network.
Quick answers
Who was awarded contract SPE2DR26FG1EN?
SPE2DR26FG1EN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FG1EN worth?
The government has obligated $60,885 on SPE2DR26FG1EN.
Is contract SPE2DR26FG1EN an order under another contract?
Yes. SPE2DR26FG1EN is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG1EN competed?
The extent of competition for SPE2DR26FG1EN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award